3 Results
Guidelines and Advice
Status: Current
ID: GL 4-1
Version: 2
ID: GL 4-1
Version: 2
Jan 2021
Drug
Mar 2021
Guidelines and Advice
Status: Current
ID: ES 30-1
ID: ES 30-1
Mar 2021